SHARPE·IQStart free
Menu
TodayResearchEarningsToolsPricingSign in
SOLV reported Q3 2026 results. The stock moved +3.7% on the print.
SOLVearnings

Earnings reactions, page 6

Solventum (SOLV) Q3 FY2026 earnings

November 6, 2026 · SharpeIQ Research Desk

Reported results

  • Sales of $1.9 billion decreased 7.0% on a reported basis and 2.8% on an organic basis.
  • GAAP diluted earnings per share were $(0.07).
  • Adjusted diluted earnings per share were $1.45, representing a 3.6% decrease.
  • Operating cash flow was $177 million and free cash flow was $97 million.
  • GAAP operating income margin was 3.5%.
  • Adjusted operating income margin was 19.9%.

Guidance

  • Expects full-year organic sales growth toward the high end of +2.5% to +3.0% range (toward the high end of +3.5% to +4.0% excluding ~100 bps of SKU exit impact).
  • Increases full-year adjusted EPS guidance to $7.20 to $7.30.
  • Affirming free cash flow in the range of $200 million to $300 million.

Price and volatility reaction

The stock moved +3.7% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -7.6 vol points across the event (constant-maturity series — not the front-week crush).

MeasureValueBasis
Close before release87.182026-11-05
Close after release90.382026-11-06
Realised move+3.7%close to close
30d ATM IV change-7.6 vol ptsconstant-maturity series, not the front expiry
Price and volatility reaction. Closes either side of the release. No front-expiry chain on file for a straddle expected move. SharpeIQ — listed option chain and price_history

Source

The figures above come from the earnings release the company filed with the SEC on 2026-11-05 (8-K, Item 2.02). Read the original filing on sec.gov.

See this live in SharpeIQ

IV rank, historical IV and the single-ticker tools. The scanner and AI research are paid plans.

Open IV Rank →